Zenitar's in vitro drug screening platform is designed to address unmet clinical needs. It reconstructs patient-specific tumor microenvironments, including drug-resistant conditions, to enable high-throughput and precise personalized drug screening. The platform aims to develop clinically actionable screening systems and therapeutic strategies.